Zelos Therapeutics names new CFO

Prior to joining Zelos Therapeutics, Mr Roemer worked at Pharmasset from 1999 through 2008. Before joining Pharmasset, Mr Roemer was a healthcare consultant for Booz-Allen & Hamilton and Deloitte Consulting, and he also held various operational roles at Bank of America.

Mr Roemer received a BS in business administration from Georgetown University and MBA and MPH degrees from Emory University’s Goizueta Business School and Rollins School of Public Health.

Brian MacDonald, CEO of Zelos, said: “We are confident that Alan’s proven fundraising, investor relations and operations expertise will be instrumental as Zelos explores multiple financing and strategic options to support the next phase of our long-term development strategy.”